Related Experiment Video

Updated: Jul 2, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Rational targeting of Notch signaling in cancer

P Rizzo1, C Osipo, K Foreman

  • 1Breast Cancer Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, IL 60163, USA.

Oncogene
|September 2, 2008
PubMed

Insights

Notch signaling promotes solid tumors, especially breast cancer. Inhibiting this pathway shows promise for cancer therapy, but requires better understanding of its regulation and interactions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Notch signaling is implicated in solid tumor progression, notably in breast cancer.
  • Notch pathway modulation is a focus for novel cancer therapeutics, particularly targeting cancer stem cells.
  • Understanding Notch pathway regulation and cross-talk is crucial for effective cancer treatment.

Purpose of the Study:

  • To review the current understanding of Notch signaling in oncology.
  • To explore the therapeutic potential and challenges of targeting Notch pathway in cancer.
  • To discuss the development of molecular diagnostics and combination strategies for Notch-targeted therapies.

Main Methods:

  • Review of preclinical and clinical evidence on Notch signaling in cancer.
  • Analysis of Notch pathway interactions with other therapeutic targets.
  • Discussion of diagnostic and toxicity considerations for Notch inhibitors.

Main Results:

  • Evidence supports a pro-oncogenic role for Notch signaling in various solid tumors.
  • Notch inhibitors, like gamma-secretase inhibitors, are under investigation as cancer treatments.
  • The role of Notch in cancer stem cells highlights its therapeutic relevance.

Conclusions:

  • Targeting Notch signaling offers therapeutic opportunities but requires deeper insights into its complex regulation.
  • Developing predictive biomarkers and managing toxicities are key challenges for Notch-targeted cancer therapy.
  • Understanding pathway cross-talk is essential for designing effective combination regimens.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...